BRIEF-Arena Pharmaceuticals, Eisai receive 'paragraph IV certification'
August 25, 2016 at 06:20 AM EDT
* Co and Eisai Inc have received a 'paragraph IV certification' notification with respect to patents for Belviq
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.